Vivian Chen Email

General Accountant . Flexogenix

Current Roles

Employees:
27
Revenue:
$5.1M
About
For millions of patients experiencing joint pain, facing the prospect of joint replacement surgery along with all of the associated risks and potential unwanted side effects, Flexogenix provides a cost-effective nonsurgical alternative with little to no post-procedural downtime, with most patients able to resume normal activity the same day of the procedure. Treatments are physician administered, FDA approved and, in most cases, completely covered by medical insurance. We custom tailor treatment to each person’s individual needs. Flexogenix offers a no-obligation consultation. If you are a candidate, a medical evaluation will follow and you will receive a detailed treatment plan capitalizing on the latest medical technology focusing on joint viscosupplementation and regenerative therapy, helping to reduce degenerative deterioration and musculoskeletal pain without dangerous side effects or undergoing surgery. At Flexogenix, we share your view that surgery should and can be a last resort. Our professionally trained medical staff will guide you through the entire process. An accurate diagnosis provided by a board certified physician, coupled with a multidisciplinary approach, maximizes the success rate of therapy.
Flexogenix Address
400 Ashville Avenue, Suite 330
Cary, NC
United States
Flexogenix Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.